Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience

Mariarita Sciumè, Daniele Vincenti, Gianluigi Reda, Nicola Orofino, Ramona Cassin, Diana Giannarelli, Gianluca Gaidano, Davide Rossi, Agostino Cortelezzi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience'. Together they form a unique fingerprint.

Medicine & Life Sciences